BCLI: Preparing to Initiate Phase 3b Trial of NurOwn Before End of 2024
On July 8, 2024, BrainStorm Cell Therapeutics, Inc. (BCLI) conducted a mid-year conference call to provide an update on the status of the...
BrainStorm Cell Therapeutics (BCLI) Initiation 11062024
BrainStorm Cell Therapeutics Inc. (Nasdaq: BCLI, Biotech) is focused on developing autologous mesenchymal stem cell (MSC) therapies for the...
BrainStorm Cell Therapeutics Inc Core Investment Case 13032024
BrainStorm Cell Therapeutics Inc. (Nasdaq: BCLI) is a biotechnology company focused on developing autologous mesenchymal stem cell (MSC) therapies...
Abbvie Inc - Regenerative Healthcare - Stem Cells & ALS Thematic 10062024
Regenerative medicine remains an extremely exciting area of healthcare with vast investment potential. In spite of the usual setbacks in valuation...
No more insights